Welcome to the Molecular Immunology and Oncology Research Group. We are a team of dedicated scientists and researchers committed to unraveling the complex cellular and molecular mechanisms that drive cancer development and immune system responses. By bridging the gap between molecular biology and clinical application, our ultimate goal is to pave the way for next-generation targeted therapies and innovative immunotherapies.
Our research strategy is built upon a dual-pillar roadmap that explores the critical intersection of oncology and the immune system:
We investigate the fundamental biology of tumors, with a specific emphasis on Cancer Stem Cells (CSCs). Because CSCs play a critical role in tumor initiation, therapy resistance, and metastasis, our research focuses on identifying the specific molecular pathways that sustain them.
The immune system is our most powerful weapon against disease. Our work investigates the signaling pathways, cellular interactions, and genetic mechanisms that govern immune responses.
To be a internationally recognized center of excellence in molecular biomedical research, driving transformative discoveries that reshape the future of cancer treatment and immunotherapy.
Advance Scientific Frontiers: To push the boundaries of biomedical science through rigorous, high-impact molecular research.
Translational Impact: To actively translate our laboratory discoveries into meaningful, real-world clinical solutions for cancer patients.
Nurture Future Innovators: To mentor and train the next generation of scientific leaders, clinicians, and researchers.
About Us